Mixed Protein-DNA Gel Particles for DNA Delivery: Role of Protein Composition and Preparation Method on Biocompatibility

dc.contributor.authorMorán Badenas, María del Carmen
dc.contributor.authorNogueira, Daniele R.
dc.contributor.authorVinardell Martínez-Hidalgo, Ma. Pilar
dc.contributor.authorMiguel, M. Graça
dc.contributor.authorLindman, Björn, 1942-
dc.date.accessioned2019-02-05T16:15:08Z
dc.date.available2019-02-05T16:15:08Z
dc.date.issued2013-07-19
dc.date.updated2019-02-05T16:15:08Z
dc.description.abstractMixtures of two cationic proteins were used to prepare protein-DNA gel particles, employing associative phase separation and interfacial diffusion (Morán et al., 2009a). By mixing the two proteins, we have obtained particles that displayed higher loading efficiency and loading capacity values than those obtained in single-protein systems. However, nothing is known about the adverse effects on haemocompatibility and cytotoxicity of these protein-DNA gel particles. Here, we examined the interaction of protein-DNA gel particles obtained by two different preparation methods, and their components, with red blood cells and established cells. From a haemolytic point of view, these protein-DNA gel particles were demonstrated to be promising long-term blood-contacting medical devices. Safety evaluation with the established cell lines revealed that, in comparison with proteins in solution, the cytotoxicity was reduced when administered in the protein-DNA systems. In comparison with large-sized particles, the cytotoxic responses of small-sized protein-DNA gel particles showed to be strongly dependent of both the protein composition and the cell line being the tumour cell line HeLa more sensitive to the deleterious effects of the mixed protein-based particles. The observed trends in haemolysis and cell viabilities were in agreement with the degree of complexation values obtained for the protein-DNA gel particles prepared by both preparation methods.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec627179
dc.identifier.issn0378-5173
dc.identifier.urihttps://hdl.handle.net/2445/127935
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.ijpharm.2013.06.041
dc.relation.ispartofInternational Journal of Pharmaceutics, 2013, vol. 454, num. 1, p. 192-203
dc.relation.urihttps://doi.org/10.1016/j.ijpharm.2013.06.041
dc.rights(c) Elsevier B.V., 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationGels (Farmàcia)
dc.subject.classificationADN
dc.subject.classificationPartícules (Matèria)
dc.subject.classificationMort cel·lular
dc.subject.classificationCàncer
dc.subject.otherGels (Pharmacy)
dc.subject.otherDNA
dc.subject.otherParticles
dc.subject.otherCell death
dc.subject.otherCancer
dc.titleMixed Protein-DNA Gel Particles for DNA Delivery: Role of Protein Composition and Preparation Method on Biocompatibility
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
627179.pdf
Mida:
696.75 KB
Format:
Adobe Portable Document Format